Sanofi-aventis receives Investment Bank Analyst Rating Update
- ByInvesting.com-
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA (NASDAQ: SNY) presented results from a Phase 3 study of Dupixent (dupilumab) in adults currently on maximal...
The court said Amgen patents relating to its cholesterol drug Repatha shouldn’t have been granted by the patent office, handing a victory to rival pharmaceutical firm Sanofi.
'Innovation is powered by more than just money,' writes Sanofi CEO Paul Hudson.
CEOs of Eli Lilly And Company (NYSE: LLY), Novo Nordisk A/S (NYSE: NVO), Sanofi SA (NASDAQ: SNY), and PBM executives from Cigna Group's (NYSE: CI) Express Scripts, and UnitedHealth...
The race to tap the respiratory syncytial virus (RSV) this season intensifies as Sanofi SA (NASDAQ: SNY) and AstraZeneca Plc (NASDAQ: AZN) have revealed data from a real-world...
He was the only executive to do so before a Senate Health Committee hearing that also included the CEOs of Novo Nordisk and Sanofi.
The FDA approved Chiesi Group and Protalix BioTherapeutics Inc's (NASDAQ: PLX) Elfabrio (pegunigalsidase alfa-iwxj) for treating adult patients with Fabry disease. The product is...
New York, USA, May 09, 2023 (GLOBE NEWSWIRE) -- Sinusitis Market to Register Stunning Growth, Estimates DelveInsight | Key Players in the Market - Optinose, GeneOne Life...